source
- #ASCO26: Grail’s cancer blood test isn’t ready for widespread use, experts sayCHICAGO — Grail's blood test, which it has pitched as a way to spot a variety of cancers early in their growth, still isn't ready to be used as a regular screening tool, experts not involved ...Endpoints · 1mo ago↗ source
- STAT+: BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDAASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.STAT · 2mo ago↗ source
- STAT+: China competition, ‘destruction’ at FDA give agency chance to restructure, Rick Pazdur saysRick Pazdur on the FDA: “We've had a lot of destruction here, and it doesn't mean that we have to just go back and say, well, let's rebuild it as…STAT